For best experience please turn on javascript and use a modern browser!
You are using a browser that is no longer supported by Microsoft. Please upgrade your browser. The site may not present itself correctly if you continue browsing.

In this meeting researchers from various disciplines in the University of Amsterdam will come together with external experts to identify key areas for joint research around vaccines against infectious diseases of global importance.

Event details of GlobeVax: Vaccines against infectious diseases of global importance (on-site)
Date 1 July 2022
Time 14:00 -17:15

Introduction

There is a huge need for accelerating the development of effective vaccines against infectious diseases of global importance, including HIV/AIDS, tuberculosis, pandemic influenza and bacterial infections. This has three challenges in common: it requires new directions in vaccine discovery, clinical development is hampered by lack of interest from industry, and the conditions needed for these vaccines to achieve health impact are not well defined, including dealing with vaccine hesitancy. These challenges bring important scientific questions for the key research areas in vaccination: discovery, clinical development and health impact. These research areas have largely been siloed. Vaccine candidates are often discovered from the perspective of technological opportunity, clinical development is seen as a matter purely for pharmaceutical industry and regulators, and the way that vaccines that come out of the pipeline should be used is seen as separate, product-driven "post-licensure" research. However, the vaccine's impact will be determined by its immunological and delivery properties, needs when implementing a vaccine should also drive clinical development, clinical development should go hand in hand with defining laboratory correlates for protection, vaccine uptake will depend on the vaccine's property as well as on public trust in the science around it, and the large-scale non-commercial funding required will be largely driven by expectations about health impact. These and other interdependencies call for multi- inter- or transdisciplinary approaches between basic biomedical sciences, epidemiology, social and behavioral sciences, economics and legal sciences.

Objectives

In this meeting researchers from various disciplines in the University of Amsterdam will come together with external experts to identify key areas for joint research around vaccines against infectious diseases of global importance.

It will also serve to explore the scope and program for a UvA Research Priority Area around this theme that would provide funding for developing joint research programs around a central theme between (researchers from) 2 or more UVA faculties.

Location

Institute for Advanced Study
Oude Turfmarkt 147
1012GC Amsterdam